The Cooper Companies, Inc. (Cooper) is a global medical device company focused on improving lives through partnerships with healthcare providers. They operate through two segments: CooperVision, which manufactures and markets contact lenses, and CooperSurgical, which offers products and services for fertility and women's health. Cooper's mission is to fulfill current needs and focus on future opportunities through innovation and strategic investment.

• Employees: "More than 16,000" (as of October 31, 2024)
• Geographic Footprint: "Around the world" with 54% of employees in the Americas, 41% in EMEA, and 5% in Asia Pacific
• Headquarters: San Ramon, California
• Founded: 1980
• Number of locations/facilities: Multiple facilities in various countries, including manufacturing and distribution sites in North America, Latin America, and Europe
• Revenue: "$3.9 billion" (FY2024)
• Market Share: Not explicitly stated in the provided text
• Key Subsidiaries/Brands: CooperVision, CooperSurgical, Biofinity, MyDay, clariti, MiSight, Paragard

• CEO: Albert G. White, III
• CFO: Brian G. Andrews
• Other Key Executives: Daniel G. McBride (Executive Vice President and Chief Operating Officer), Agostino Ricupati (Senior Vice President and Chief Accounting Officer), Nicholas S. Khadder (Vice President, General Counsel and Corporate Secretary), Holly R. Sheffield (President of CooperSurgical, Inc.), Gerard H. Warner, III (President of CooperVision, Inc.)

Information on executive tenure and background was not specified in the provided text.

• Annual Revenue: $3.9 billion (FY2024)
• Net Income: $392.3 million
• Market Cap: $17.6 billion (as of April 30, 2024, aggregate market value of shares held by non-affiliates)
• Total Assets: $12.3 billion
• Number of Employees: More than 16,000 (as of October 31, 2024)
• Key Financial Highlights: Net sales increased by 8% year-over-year, with growth in both CooperVision and CooperSurgical segments. Operating income increased by 32% year-over-year.

Cooper operates in two main segments:

• CooperVision: Offers a broad range of contact lenses, including single-use, two-week, and monthly lenses, featuring advanced materials and optics. They also offer myopia management products like the MiSight 1 day lens.
• CooperSurgical: Provides a wide array of products and services focused on fertility and women's health, including medical devices for gynecology and obstetrics, contraception, cryostorage, and genomic services.

The company operates through two business segments:

• CooperVision: Focuses on contact lens products, including spherical, toric, and multifocal lenses, as well as myopia management lenses.
• CooperSurgical: Offers products and services for fertility and women's health, including medical devices, cryostorage, and contraception.

Revenue breakdown by segment is available in the Key Financial Metrics section.

Cooper's strategy includes:

• Investing in innovation and strategic acquisitions to expand their integrated solutions model.
• Focusing on greater worldwide market penetration of recently introduced products.
• Expanding presence in existing and emerging markets organically and through acquisitions.
• Supporting the growth of all customers, including key accounts, through investments in selling, promotional, and advertising activities.
• Increasing investment in distribution and packaging capabilities to support business growth and quality service.

Cooper operates in the highly competitive medical device industry, specifically within the contact lens and women's health sectors.

• Market Position: CooperVision competes with Johnson & Johnson Vision Care, Alcon Inc., and Bausch + Lomb in the contact lens market. CooperSurgical competes with Vitrolife Group, FujiFilm-Irvine Scientific, and others in the fertility market, and with Bayer and AbbVie in the contraception market.
• Key Competitors: Johnson & Johnson Vision Care, Alcon Inc., Bausch + Lomb, Vitrolife Group, FujiFilm-Irvine Scientific, Bayer, AbbVie
• Industry Trends: The contact lens market is growing with the addition of value-added products and myopia management solutions. The women's health market is seeing a trend toward consolidation of practices, increased demand for fertility services, and a focus on reducing pregnancy complications.

• Market Risks: Adverse changes in global economic conditions, international conflicts, and competition from new products and technologies.
• Operational Risks: Disruptions in manufacturing, supply chain, and distribution operations due to natural disasters, pandemics, or cybersecurity incidents.
• Financial Risks: Fluctuations in foreign currency exchange rates, interest rate increases, and the ability to access financing.
• Regulatory Risks: Compliance with U.S. and foreign laws and regulations, including those related to medical devices, pharmaceuticals, and data privacy.
• Acquisition Risks: Failure to achieve anticipated benefits from acquisitions, integration challenges, and contingent liabilities.